1. Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus. Issue 8 (2nd August 2016) Authors: Van Der Meeren, Olivier; Peterson, James T.; Dionne, Marc; Beasley, Richard; Ebeling, Peter R.; Ferguson, Murdo; Nissen, Michael D.; Rheault, Paul; Simpson, Richard W.; De Ridder, Marc; Crasta, Priya D.; Miller, Jacqueline M.; Trofa, Andrew F. Journal: Human vaccines & immunotherapeutics Issue: Volume 12:Issue 8(2016) Page Start: 2197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Response to publications by Heyward W et al. and Kuan R et al.: Clinical and cost-effectiveness analyses, respectively, of hepatitis B vaccination—Heplisav™ compared with Engerix-B® vaccine in adults. Issue 28 (22nd June 2015) Authors: De Ridder, Marc; Curran, Desmond; Leroux-Roels, Geert Journal: Vaccine Issue: Volume 33:Issue 28(2015) Page Start: 3161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response to publications by Heyward W et al. and Kuan R et al.: Clinical and cost-effectiveness analyses, respectively, of hepatitis B vaccination—Heplisav™ compared with Engerix-B® vaccine in adults. Issue 28 (22nd June 2015) Authors: De Ridder, Marc; Curran, Desmond; Leroux-Roels, Geert Journal: Vaccine Issue: Volume 33:Issue 28(2015) Page Start: 3161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗